knowledge -WSS

knowledge

author：knowledge 2025-09-30 18:20:17 - browse：5344

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： CRISPR pioneers react to Casgevy, first gene

entertainment

WSS

Teacher posts viral 'school supply rant' with advice for parents

CRISPR pioneers react to Casgevy, first gene

Hospitals look to new technology to keep health care workers safe

Europe is fastest

Anthos stroke drug appears safer than common blood thinner

Does good food count as health care? Study aims to find out

Wikipedia

knowledge

focus

Novavax promises a turnaround & Lilly roils the obesity market

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

New air purifier tech could be key to improving indoor air quality

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Malaria cases in Florida and Texas: Here’s what you need to know

Poor hospice wound care hurts patients and families

Guidelines to prevent youth baseball injuries need more muscle

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Hepatitis C has a cure — but many Americans still lack access to it

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

knowledge

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Astellas still sees hope in its gene therapy after four deaths

Astellas still sees hope in its gene therapy after four deaths

NYU radiologists take on the challenge of expensive MRI machines

Europe is fastest

Poor hospice wound care hurts patients and families

knowledge

entertainment

hotspot

hotspot